Form 4 for PRLD Prelude Therapeutics Inc
Accepted 2023-04-06 00:00:00 ET · period of report 2023-04-04 · accession 0001562180-23-003481 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-06 | 2023-04-06 | PRLD | Huang Jane | Pres, CMO | S - Sale+OE | $6.12 | -13.3K | 24.2K | -35% | -$81.3K |
| D | 2023-04-06 | 2023-04-04 | PRLD | Huang Jane | Pres, CMO | M - OptEx | — | +37.5K | 37.5K | New | — |
| D | 2023-04-06 | 2023-04-04 | PRLD | Huang Jane | Pres, CMO | M - OptEx | $0.00 | -37.5K | 112.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-06 | S | D | 13,280 | $6.12 | 24,220 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.90 to $6.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 2 | Common | Common Stock | 2023-04-04 | M | A | 37,500 | — | 37,500 | D | — | — | (F1) Each Restricted Stock Unit ("RSUs") represents a contingent right to receive one share of Issuer's Common Stock. |
| 3 | Derivative | Restricted Stock Unit | 2023-04-04 | M | D | 37,500 | $0.00 | 112,500 | D | — · — to — | 37,500 Common Stock | (F1) Each Restricted Stock Unit ("RSUs") represents a contingent right to receive one share of Issuer's Common Stock. (F4) The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date. |